Products

Epstein-Barr virus cDNA and Antigen

Cat#	Product Name	Swiss Prot#	Size	Price (US$)	Order
PN0356	Recombinant Protein-Epstein-Barr virus Epstein-Barr nuclear antigen 3 (a.a.50 to 450)	Q69138	100 µg	1195	Order
PN0357	Recombinant Protein-Epstein-Barr virus Epstein-Barr nuclear antigen 4 (a.a.50 to 450)	Q1HVG4	100 µg	1195	Order
PN0358	Recombinant Protein-Epstein-Barr virus Epstein-Barr nuclear antigen 6 (a.a.391 to 976)	Q69140	100 µg	1195	Order
PN0359	Recombinant Protein-Epstein-Barr virus Envelope glycoprotein B GP115 (a.a.23 to 450)	P0C763	100 µg	1195	Order
PN0360	Recombinant Protein-Epstein-Barr virus Envelope glycoprotein H gp85 (a.a.19 to 450)	Q1HVD2	100 µg	1195	Order
PN0361	Recombinant Protein-Epstein-Barr virus Envelope glycoprotein L gp25 (a.a.23 to 137)	Q1HVF6	100 µg	1195	Order
PN0362	Recombinant Protein-Epstein-Barr virus Glycoprotein 42 gp42 (a.a.30 to 223)	Q1HVG2	100 µg	1195	Order
PN0363	Recombinant Protein-Epstein-Barr virus Major capsid protein (a.a.50 to 450)	P0C703	100 µg	1195	Order
PN0364	Recombinant Protein-Epstein-Barr virus Envelope glycoprotein GP340 (a.a.50 to 450)	P68343	100 µg	1195	Order
PN0365	Recombinant Protein-Epstein-Barr virus Glycoprotein 42 gp42 (a.a.30 to 223)	P03205	100 µg	1195	Order
PN0366	Recombinant Protein-Epstein-Barr virus Latent membrane protein 1 (a.a.242 to 386)	P03230	100 µg	1195	Order
PN0367	Recombinant Protein-Epstein-Barr virus Envelope glycoprotein GP340/GP220 (a.a.502 to 698)	P03200	100 µg	1195	Order
PN0368	Recombinant Protein-Epstein-Barr virus Probable capsid protein VP23 (Protein BDLF1) (a.a.39 to 301)	P25214	100 µg	1195	Order
PN0369	Recombinant Protein-Epstein-Barr virus Capsid protein VP26 (a.a.21 to 176)	P14348	100 µg	1195	Order
PN0370	Recombinant Protein-Epstein-Barr virus Apoptosis regulator BHRF1-Early antigen protein R (a.a.37 to 191)	P0C736	100 µg	1195	Order
PN0371	Recombinant Protein-Epstein-Barr virus-EBV nuclear antigen 2-EBNA-2(a.a.1 to 176)	Q3KSV2	100 µg	1195	Order
PN0372	Recombinant Protein-Epstein-Barr virus nuclear antigen EBNA-3B (a.a.50 to 450)	Q69139	100 µg	1195	Order
RPN0356	cDNA-Epstein-Barr virus Epstein-Barr nuclear antigen 3 (a.a.50 to 450)	Q69138	2 µg	2000	Order
RPN0357	cDNA-Epstein-Barr virus Epstein-Barr nuclear antigen 4 (a.a.50 to 450)	Q1HVG4	2 µg	2000	Order
RPN0358	cDNA-Epstein-Barr virus Epstein-Barr nuclear antigen 6 (a.a.391 to 976)	Q69140	2 µg	2925	Order
RPN0359	cDNA-Epstein-Barr virus Envelope glycoprotein B GP115 (a.a.23 to 450)	P0C763	2 µg	2135	Order
RPN0360	cDNA-Epstein-Barr virus Envelope glycoprotein H gp85 (a.a.19 to 450)	Q1HVD2	2 µg	2155	Order
RPN0361	cDNA-Epstein-Barr virus Envelope glycoprotein L gp25 (a.a.23 to 137)	Q1HVF6	2 µg	800	Order
RPN0362	cDNA-Epstein-Barr virus Glycoprotein 42 gp42 (a.a.30 to 223)	Q1HVG2	2 µg	965	Order
RPN0363	cDNA-Epstein-Barr virus Major capsid protein (a.a.50 to 450)	P0C703	2 µg	2000	Order
RPN0364	cDNA-Epstein-Barr virus Envelope glycoprotein GP340 (a.a.50 to 450)	P68343	2 µg	2000	Order
RPN0365	cDNA-Epstein-Barr virus Glycoprotein 42 gp42 (a.a.30 to 223)	P03205	2 µg	965	Order
RPN0366	cDNA-Epstein-Barr virus Latent membrane protein 1 (a.a.242 to 386)	P03230	2 µg	720	Order
RPN0367	cDNA-Epstein-Barr virus Envelope glycoprotein GP340/GP220 (a.a.502 to 698)	P03200	2 µg	980	Order
RPN0368	cDNA-Epstein-Barr virus Probable capsid protein VP23 (Protein BDLF1) (a.a.39 to 301)	P25214	2 µg	1310	Order
RPN0369	cDNA-Epstein-Barr virus Capsid protein VP26 (a.a.21 to 176)	P14348	2 µg	775	Order
RPN0370	cDNA-Epstein-Barr virus Apoptosis regulator BHRF1-Early antigen protein R (a.a.37 to 191)	P0C736	2 µg	770	Order
RPN0371	cDNA-Epstein-Barr virus-EBV nuclear antigen 2-EBNA-2(a.a.1 to 176)	Q3KSV2	2 µg	875	Order
RPN0372	cDNA-Epstein-Barr virus nuclear antigen EBNA-3B (a.a.50 to 450)	Q69139	2 µg	2000	Order

Please contact us for a quote on larger sizes …

Epstein-Barr virus cDNA and recombinant antigen

Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
Recombinant protein applications: Western Blot may be used for other applications determined by the user.
Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
Protein Activity: N/A
Protein Tag: Contains A 6x histidine tag at N-terminus.
Protein Formulation: Liquid
Source: Produced from E. coli

The EBV genome has been fully sequenced, and it has been found that it is highly variable among different strains of the virus. The variability in the genome is responsible for the diversity in viral antigenicity and pathogenicity. The virus genome encodes many proteins, including:

Barr nuclear antigen 3 (EBNA-3): This is a family of nuclear proteins that play a role in regulating the expression of viral and host genes.

Barr nuclear antigen 4 (EBNA-4): This is another nuclear protein that is involved in regulating gene expression.

Barr nuclear antigen 6 (EBNA-6): This is a family of nuclear proteins that are involved in regulating the replication and maintenance of the viral genome.

B GP115: This is a glycoprotein that is involved in viral entry and infectivity.

H gp85 and L gp25: These are glycoproteins that form the viral envelope and are involved in viral entry.

GP42: This is a glycoprotein that binds to host cells and facilitates viral entry.

Major capsid protein: This is a structural protein that forms the outer shell of the virus.

GP340: This is a glycoprotein that binds to host cells and facilitates viral entry.

Latent membrane protein 1 (LMP1): This is a membrane protein that is involved in promoting cell survival and proliferation.

VP23 and VP26: These are structural proteins that form the inner shell of the virus.

BHRF1: This is a viral protein that is involved in inhibiting apoptosis and promoting viral replication.

EBNA-2: This is a nuclear protein that is involved in regulating the expression of viral and host genes.

EBNA-3B: This is a nuclear protein that is involved in regulating gene expression and inhibiting apoptosis.

Many of these proteins are involved in viral replication, viral entry, and modulation of host cell functions to promote viral persistence. Some of these proteins also play a role in the pathogenesis of EBV-associated diseases.

Understanding the functions and interactions of these proteins is crucial for developing effective treatments and prevention strategies for EBV-associated diseases. Ongoing research is focused on uncovering more about the virus and its proteins, with the goal of ultimately finding a way to control and eradicate the disease.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.

Bioclone

Products

Epstein-Barr virus cDNA and Antigen

Learn More

Bioclone Inc.

Welcome to BitClone